Ziegler Christoph Samuel insider trades
Ziegler Christoph Samuel has filed 1 Form 4 with the SEC that we hold, all for Veraxa Biotech AG - Post de-SPAC (VRXA), as Director. Across all of them we count 1 purchase worth $32.7K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($32.7K) and 0 sales ($0). The largest single trade was a purchase of 30,000 shares of Veraxa Biotech AG - Post de-SPAC worth $32.7K, dated 2026-10-20. The first filing on our record is dated 2026-10-21 and the latest 2026-10-21.
Veraxa Biotech AG - Post de-SPAC (VRXA)
Director · 1 filing · 1 purchase or sale
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2026-10-20 | P, purchase reported on Form 4 | 30,000 | $32.7K | 2026-10-21 | SEC |
Source
Counted from the Form 4 filings this reporting owner (SEC CIK 2123272) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
